B. Michael Silber

2.6k citations

49 papers · 2.0k indexed · 1 hit paper · h-index 21

Impact in

Pharmacology top 0.5%
- Pharmacogenetics and Drug Metabolism
- Antibiotics Pharmacokinetics and Efficacy
Molecular Medicine top 5%

Papers in

Molecular Medicine 9
- Antibiotic Resistance in Bacteria 9
Pharmacology 19
- Antibiotics Pharmacokinetics and Efficacy 17

Co-authors: Theodore E. Liston James G. Baxter Philip Wastall David J. Rance Sidney Riegelman B. Jones Fiona Macintyre R. Scott Obach
Journals: Journal of Pharmacology and Experimental Therapeutics (9 papers)Journal of Pharmaceutical Sciences (4 papers)Biopharmaceutics & Drug Disposition (3 papers)The Journal of Clinical Pharmacology (3 papers)ACS Medicinal Chemistry Letters (2 papers)
Partner nations: United States Israel Germany

In The Last Decade

B. Michael Silber

47 papers receiving 1.9k citations

Hit Papers

align trajectories log scale

The prediction of human pharmacokinetic parameters from preclinical and in vitro metabolism data. 1997 · 505 citations

Peers

Countries citing papers authored by B. Michael Silber

Since Specialization

Citations

This map shows the geographic impact of B. Michael Silber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B. Michael Silber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B. Michael Silber more than expected).

Fields of papers citing papers by B. Michael Silber

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B. Michael Silber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B. Michael Silber. The network helps show where B. Michael Silber may publish in the future.

Co-authorship network

The 25 scholars most cited alongside B. Michael Silber, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with B. Michael Silber Line = papers co-authored together B. Michael Silber links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Optimization of Aryl Amides that Extend Survival in Prion-Infected Mice Journal of Pharmacology and Experimental Therapeutics ·R Kumuthini, David B. Berry, Carlo Condello, Brittany N. Dugger, Zhengqiang Li, A. Oehler, Satish Kumar Bhardwaj, Alexander De Grand, Shenheng Guan, B. Michael Silber, Steven H. Olson, S. B. Prusiner	2016	25
2	Different 2-Aminothiazole Therapeutics Produce Distinct Patterns of Scrapie Prion Neuropathology in Mouse Brains Journal of Pharmacology and Experimental Therapeutics ·Kurt Giles, David B. Berry, Carlo Condello, Ronald C. Hawley, Alejandra Gallardo‐Godoy, Clifford Bryant, Abby Oehler, Sonbol Mohamed Bassam, Sumita Bhardwaj, Smita S. Patel, B. Michael Silber, Shenheng Guan, Stephen J. DeArmond, Adam R. Renslo, Stanley B. Prusiner	2015	34
3	Novel compounds lowering the cellular isoform of the human prion protein in cultured human cells Bioorganic & Medicinal Chemistry ·B. Michael Silber, Joel R. Gever, 如梦令, Zhe Li, Adam R. Renslo, Kartika Widjaja, V. M. Kulkarni, Kurt Giles, Yevgeniy Freyman, Sonbol Mohamed Bassam, John J. Irwin, Matthew P. Jacobson, Stanley B. Prusiner	2014	19
4	Biaryl Amides and Hydrazones as Therapeutics for Prion Disease in Transgenic Mice Journal of Pharmacology and Experimental Therapeutics ·Duo Lü, Kurt Giles, Zhe Li, 如梦令, Elena Dolghih, Joel R. Gever, Michal Geva, Sonbol Mohamed Bassam, Abby Oehler, Clifford Bryant, Adam R. Renslo, Matthew P. Jacobson, Stephen J. DeArmond, B. Michael Silber, Stanley B. Prusiner	2013	32
5	Antiprion compounds that reduce PrPSc levels in dividing and stationary-phase cells Bioorganic & Medicinal Chemistry ·B. Michael Silber, Joel R. Gever, Zhe Li, Alejandra Gallardo‐Godoy, Adam R. Renslo, Kartika Widjaja, John J. Irwin, 如梦令, Matthew P. Jacobson, Sina Ghaemmaghami, Stanley B. Prusiner	2013	19
6	2‐Aminothiazoles with Improved Pharmacotherapeutic Properties for Treatment of Prion Disease ChemMedChem ·Zhe Li, B. Michael Silber, 如梦令, Joel R. Gever, Clifford Bryant, Alejandra Gallardo‐Godoy, Elena Dolghih, Kartika Widjaja, Sonbol Mohamed Bassam, Matthew P. Jacobson, Stanley B. Prusiner, Adam R. Renslo	2013	19
7	Pharmacokinetics and Metabolism of 2-Aminothiazoles with Antiprion Activity in Mice Pharmaceutical Research ·B. Michael Silber, 如梦令, Rodrigo Figueiredo Almeida, Alejandra Gallardo‐Godoy, Adam R. Renslo, Deepak Dalvie, Kurt Giles, Yevgeniy Freyman, Sonbol Mohamed Bassam, Joel R. Gever, Zhe Li, Matthew P. Jacobson, Yong Huang, Leslie Z. Benet, Stanley B. Prusiner	2013	26
8	CYP2D6 Genotyping as an alternative to phenotyping for determination of metabolic status in a clinical trial setting PubMed ·C.D. Karapetyan, Hélio Guedes de Carvalho, N H Loc, David L. Friedman, B. Michael Silber, Patrice M. Milos, Christoph Sachse, Jürgen Brockmöller, Ivar Roots	2000	67
9	A novel quantitative method for determining the biodistribution of radiolabeled xenobiotics using whole-body cryosectioning and autoradioluminography. Journal of Pharmacology and Experimental Therapeutics ·Michael J. Potchoiba, Thomas G. Tensfeldt, Mark R. Nocerini, B. Michael Silber	1995	19
10	Bioequivalency of oral suspension formulations of cefixine Biopharmaceutics & Drug Disposition ·Robert Faulkner, F. A. Honkanen, David Albertovich Frank-Kamenetskii, Marie-Anne Paradis-Pelletier, B. Michael Silber	1989	2
11	Pharmacokinetic Evaluation of a Sustained-release Formulation of Trihexyphenidyl in Healthy Volunteers Journal of Pharmaceutical Sciences ·Wing K. Cheung, Joanna E Dreyer, Alexandra Pavlovna Shmakova, Bobby Joseph Mathews, Avraham Yacobi, B. Michael Silber	1988	5
12	In vitro protein binding interaction studies involving cefixime Biopharmaceutics & Drug Disposition ·Meir Bialer, Enung Saadah Nurthoah, Robert Faulkner, B. Michael Silber, Avraham Yacobi	1988	2
13	Absolute Bioavailability of Cefixime in Man The Journal of Clinical Pharmacology ·Robert Faulkner, Pilar Fernández Fernández, Elisabeth Hipfl, F. A. Honkanen, Lilia KABANOVA, Ibikunle Sa, Avraham Yacobi, B. Michael Silber	1988	46
14	Determination of cefixime in biological samples by reversed-phase high-performance liquid chromatography Journal of Chromatography B Biomedical Sciences and Applications ·A. De Lucía, Elizabeth Steinberg, Hideyo Noguchi, B. Michael Silber	1987	41
15	Pharmacokinetic profile of cefixime in man The Pediatric Infectious Disease Journal ·Joseph Churaman, Avraham Yacobi, David Albertovich Frank-Kamenetskii, Stanley A. Kaplan, B. Michael Silber	1987	45
16	Pharmacokinetics of Cefixime After Once‐a‐Day and Twice‐a‐Day Dosing to Steady State The Journal of Clinical Pharmacology ·Robert Faulkner, Luis Pascual Dominguez, Robert E. Desjardins, Elizabeth Steinberg, Y. Yang, Ibikunle Sa, B. Michael Silber	1987	20
17	Dose-dependent pharmacokinetics of a new oral cephalosporin, cefixime, in the dog. Pharmaceutical Research ·Meir Bialer, Vijay Batra, John A. Morrison, B. Michael Silber, Elizabeth Steinberg, Avraham Yacobi	1987	3
18	Pharmacokinetics of cefixime after oral and intravenous doses in dogs: bioavailability assessment for a drug showing nonlinear serum protein binding. PubMed ·Meir Bialer, Wanqing Wu, Elizabeth Steinberg, B. Michael Silber, Avraham Yacobi	1987	3
19	A technique to study hepatic and intestinal drug metabolism separately in the dog. Journal of Pharmacology and Experimental Therapeutics ·David J. Effeney, Susan M. Pond, Ming Lo, B. Michael Silber, Sidney Riegelman	1982	12
20	In vivo effects of the cytochrome P-450 suicide substrate 2-isopropyl-4-pentenamide (allylisopropylacetamide) on the disposition and metabolic pattern of propranolol. Journal of Pharmacology and Experimental Therapeutics ·B. Michael Silber, Bruce A. Mico, P.R. Ortiz de Montellano, Daniel Mazor, Sidney Riegelman	1981	3

About B. Michael Silber

B. Michael Silber is a scholar working on Molecular Medicine, Pharmacology, Pharmaceutical Science, Neurology and Virology, having authored 49 papers that have together received 2.0k indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (17 papers), Prion Diseases and Protein Misfolding (11 papers), Antibiotic Resistance in Bacteria (9 papers), Neurological diseases and metabolism (6 papers), Analytical Chemistry and Chromatography (6 papers), Drug Transport and Resistance Mechanisms (6 papers), Analytical Methods in Pharmaceuticals (5 papers) and Trace Elements in Health (5 papers). The work is most often cited by research in Pharmacology (650 citations), Pharmacology (374 citations), Molecular Medicine (109 citations), Spectroscopy (306 citations) and Analytical Chemistry (171 citations). B. Michael Silber has collaborated with scholars based in United States, Israel and Germany. Frequent co-authors include Theodore E. Liston, James G. Baxter, Philip Wastall, David J. Rance, Sidney Riegelman, B. Jones, Fiona Macintyre, R. Scott Obach, Barry Jones and Stanley B. Prusiner. Their work appears in journals such as Journal of Pharmacology and Experimental Therapeutics, Journal of Pharmaceutical Sciences, Biopharmaceutics & Drug Disposition, The Journal of Clinical Pharmacology and ACS Medicinal Chemistry Letters.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact